TEVA PHARMACEUTICAL-SP ADR (TEVA) Stock Balance Sheet
NYSE:TEVA - New York Stock Exchange, Inc. - US8816242098 - ADR - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 1.70B | 3.30B | 3.23B | 2.80B | 2.17B | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 3.38B | 3.06B | 3.41B | 3.70B | 4.53B | |||
| Inventories | 3.25B | 3.01B | 4.02B | 3.83B | 3.82B | |||
| Other Current Assets | 3.20B | 3.19B | 1.83B | 1.72B | 2.06B | |||
| Total Current Assets | 11.53B | 12.55B | 12.49B | 12.05B | 12.57B | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.99B | 4.95B | 6.15B | 6.16B | 6.48B | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Goodwill | 15.48B | 15.15B | 17.18B | 17.63B | 20.04B | |||
| Intangibles | 4.19B | 4.42B | 5.39B | 6.27B | 7.47B | |||
| Other Non-Current Assets | 2.23B | 2.26B | 2.28B | 1.90B | 1.11B | |||
| Total Non-Current Assets | 26.89B | 26.77B | 30.99B | 31.96B | 35.09B | |||
| TOTAL ASSETS | 38.41B | 39.33B | 43.48B | 44.01B | 47.67B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 23.00M | 23.00M | 23.00M | 23.00M | |||
| Current Portion Of LT Debt. | 421.00M | 1.76B | 1.65B | 2.09B | 1.40B | |||
| Accrued Expenses | 3.43B | 3.50B | 3.48B | 2.81B | 2.88B | |||
| Accounts Payable | 2.29B | 2.20B | 2.60B | 1.89B | 1.69B | |||
| Other Current Liabilities | 5.02B | 5.31B | 4.49B | 4.66B | 5.04B | |||
| Total Current Liabilities | 11.16B | 12.80B | 12.25B | 11.47B | 11.03B | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 16.23B | 16.00B | 18.16B | 19.10B | 21.62B | |||
| Deferred Taxes/Income | 461.00M | 483.00M | 606.00M | 548.00M | 784.00M | |||
| Other Non-Current Liabilities | 4.30B | 4.33B | 4.34B | 4.29B | 2.99B | |||
| Total Non-Current Liabilities | 21.00B | 21.16B | 23.73B | 24.74B | 26.36B | |||
| TOTAL LIABILITIES | 32.15B | 33.95B | 35.97B | 36.21B | 37.39B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | N/A | -15.17B | -13.53B | -12.97B | -10.53B | |||
| Additional Paid In Capital | N/A | 27.76B | 27.81B | 27.69B | 27.56B | |||
| Minority Interest | 7.00M | 347.00M | 620.00M | 794.00M | 966.00M | |||
| Common Shares | N/A | 58.00M | 57.00M | 57.00M | 57.00M | |||
| Treasury Stock | N/A | -4.13B | -4.13B | -4.13B | -4.13B | |||
| Other Shareholders' Equity | 6.26B | -3.15B | -2.70B | -2.84B | -2.68B | |||
| Shares Outstanding | 1.14B | 1.14B | 1.13B | 1.13B | 1.11B | |||
| Tangible Book Value per Share | -11.82 | -12.52 | -13.43 | -14.36 | -15.61 | |||
| Total Shareholders' Equity | 6.26B | 5.37B | 7.51B | 7.80B | 10.28B | |||
| TOTAL LIABILITIES AND EQUITY | 38.41B | 39.33B | 43.48B | 44.01B | 47.67B | |||
| Statistics | ||||||||
| Debt/Equity | 2.59 | 2.98 | 2.42 | 2.45 | 2.11 | |||
| Current Ratio | 1.03 | 0.98 | 1.02 | 1.05 | 1.14 | |||
| Return On Assets (ROA) | -3.35% | -4.17% | -1.29% | -5.56% | 0.87% | |||
| Return On Equity (ROE) | -20.54% | -30.50% | -7.45% | -31.34% | 4.06% | |||
| Return On Invested Capital (ROIC) | 10.69% | 10.67% | 8.95% | 7.73% | 7.37% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 11.40% | 12.19% | 9.98% | 8.45% | 7.83% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 49.41% | 76.86% | 51.16% | 42.93% | 38.62% | |||
All data in USD , ROIC based on taxRate of 0.21